Listek et al. described some technical concerns for the
single
transgenic hybridoma selection method (STHSM) that we developed. In
this work, we developed the STHSM to screen hapten-specific hybridoma
cells based on a streptavidin-labeled antigen originally proposed
by Listek et al. that was used for the selection of OVA-specific hybridoma.
Due to the obvious differences between hapten with a single epitope
and protein with multiple epitopes, we significantly innovated the
specific procedures in the STHSM that could answer the questions raised
by Listek’s group.